Treatment of hemophilia with fitusiran
US-2024027478-A1 · Jan 25, 2024 · US
US9733262B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9733262-B2 |
| Application number | US-201514658911-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 16, 2015 |
| Priority date | May 20, 2009 |
| Publication date | Aug 15, 2017 |
| Grant date | Aug 15, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for measuring blood coagulation, including: preparing a reaction solution including a plasma specimen, a blood coagulation activator, and at least one of amino-guanidine and an acid addition salt thereof; and measuring blood coagulation time by detecting a turbidity change in the reaction solution.
Opening claim text (preview).
The invention claimed is: 1. A method for measuring blood coagulation, comprising: preparing a reaction solution comprising a plasma specimen, a blood coagulation activator, and at least one of amino-guanidine and an acid addition salt thereof; and measuring blood coagulation time by detecting a turbidity change in the reaction solution. 2. The method according to claim 1 , wherein the turbidity change is detected by a method of detecting a scattered light amount. 3. The method according to claim 1 , wherein the amino-guanidine or an acid addition salt thereof is added to the reaction solution together with a specimen diluent for measuring blood coagulation. 4. The method according to claim 2 , wherein the amino-guanidine or an acid addition salt thereof is added to the reaction solution together with a specimen diluent for measuring blood coagulation. 5. The method according to claim 3 , wherein the specimen diluent is a specimen diluent for measuring fibrinogen. 6. The method according to claim 4 , wherein the specimen diluent is a specimen diluent for measuring fibrinogen. 7. The method according to claim 1 , wherein the blood coagulation activator is thrombin. 8. The method according to claim 5 , wherein the blood coagulation activator is thrombin. 9. The method according to claim 6 , wherein the blood coagulation activator is thrombin. 10. The method according to claim 5 , wherein the measuring of blood coagulation time is performed by a fibrinogen measurement method. 11. The method according to claim 6 , wherein the measuring of blood coagulation time is performed by a fibrinogen measurement method. 12. The method according to claim 7 , wherein the measuring of blood coagulation time is performed by a fibrinogen measurement method. 13. The method according to claim 9 , wherein the measuring of blood coagulation time is performed by a fibrinogen measurement method. 14. The method according to claim 9 , wherein the measuring of blood coagulation time is performed by a fibrinogen measurement method. 15. The method according to claim 1 , wherein the reaction solution comprises amino-guanidine. 16. The method according to claim 1 , wherein the reaction solution comprises an acid addition salt of amino-guanidine. 17. The method according to claim 1 , wherein the acid addition salt of amino-guanidine is at least one salt selected from the group consisting of a hydrochloride salt of amino-guanidine, a sulfate salt of amino-guanidine, a nitrate salt of amino-guanidine, a phosphate salt of amino-guanidine, and a sulfamate salt of amino-guanidine. 18. The method according to claim 1 , wherein the at least one of amino-guanidine and an acid addition salt thereof is amino-guanidine hydrochloride. 19. The method according to claim 1 , wherein the amino-guanidine has the formula where R 1 is an amino group. 20. The method according to claim 17 , wherein the amino-guanidine has the formula where R 1 is an amino group.
being further substituted by carboxyl groups · CPC title
Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors · CPC title
Compounds containing any of the groups [IMAGE cpc-sch-C07C-0974.gif], e.g. aminoguanidine · CPC title
involving blood coagulating time {or factors, or their receptors} · CPC title
Amidines ([IMAGE cpc-sch-A61K-1029.gif]), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.